DIFLOXACIN METABOLISM AND PHARMACOKINETICS IN HUMANS AFTER SINGLE ORAL DOSES

被引：53
作者：
GRANNEMAN, GR
SNYDER, KM
SHU, VS
机构：
[1] ABBOTT LABS,DEPT CLIN RES,ABBOTT PK,IL 60064
[2] ABBOTT LABS,DEPT CLIN STAT,ABBOTT PK,IL 60064
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1986年 / 30卷 / 05期
关键词：
D O I：
10.1128/AAC.30.5.689
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：689 / 693
页数：5
相关论文
共 27 条
[1]  
Akaike H., 1976, MATH SCI, V14, P5
[2]   MULTIPLE-DOSE CIPROFLOXACIN KINETICS IN NORMAL SUBJECTS [J].
ARONOFF, GE ;
KENNER, CH ;
SLOAN, RS ;
POTTRATZ, ST .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (03) :384-388
[3]   DOSE-DEPENDENT PHARMACOKINETIC STUDY OF PEFLOXACIN, A NEW ANTIBACTERIAL AGENT, IN HUMANS [J].
BARRE, J ;
HOUIN, G ;
TILLEMENT, JP .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (10) :1379-1382
[4]   INVITRO EVALUATION OF A-56619 AND A-56620, 2 NEW QUINOLONES [J].
BARRY, AL ;
THORNSBERRY, C ;
JONES, RN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (01) :40-43
[5]   DETERMINATION OF NORFLOXACIN, A NEW NALIDIXIC-ACID ANALOG, IN HUMAN-SERUM AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
BOPPANA, VK ;
SWANSON, BN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (05) :808-810
[6]  
CHU D T W, 1985, Drugs of the Future, V10, P543
[7]   PHARMACOKINETICS AND TISSUE PENETRATION OF CIPROFLOXACIN [J].
CRUMP, B ;
WISE, R ;
DENT, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (05) :784-786
[8]  
DISCHE Z, 1947, J BIOL CHEM, V167, P189
[9]   PHARMACOKINETICS OF NORFLOXACIN IN HEALTHY-VOLUNTEERS AND PATIENTS WITH RENAL AND HEPATIC DAMAGE [J].
EANDI, M ;
VIANO, I ;
DINOLA, F ;
LEONE, L ;
GENAZZANI, E .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (03) :253-259
[10]   INVITRO ACTIVITIES OF THE QUINOLONE ANTIMICROBIAL AGENTS A-56619 AND A-56620 [J].
ELIOPOULOS, GM ;
MOELLERING, AE ;
REISZNER, E ;
MOELLERING, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (04) :514-520
123